Exhibit 10.1

 

AMENDMENT NO. 3 TO MARKETING REPRESENTATION AGREEMENT

 

This Amendment No. 3 to Marketing Representation Agreement (the “Amendment
No. 3”) is made this 27th day of January, 2006, by and among (i) Novoste
Corporation, a Florida corporation with its principal place of business at 4350
International Boulevard, Norcross, Georgia 30093 (“Novoste”), (ii) Best
Vascular, Inc., a Delaware corporation with its principal place of business at
7643 Fullerton Road, Springfield, Virginia 22153 (“Representative”), and
(iii) Best Medical International, Inc., a Virginia corporation which is an
affiliate of Representative, with its principal place of business at 7643
Fullerton Road, Springfield, Virginia 22153 (“BMI”);

 

WHEREAS, Novoste, Representative and BMI entered into that certain Marketing
Representation Agreement, dated as of August 25, 2005, as amended October 12,
2005 pursuant to Amendment No. 1 to Marketing Representation Agreement and as
further amended November 30, 2005 pursuant to Amendment No. 2 to Marketing
Representation Agreement (as amended, the “Marketing Representation Agreement”),
pursuant to which Novoste engaged Representative to market, demonstrate and
solicit orders for various products with respect to Seller’s VBT Business; and

 

WHEREAS, Novoste, Representative and BMI desire to amend the provisions of the
Marketing Representation Agreement relating to its term; and

 

WHEREAS, the parties hereto are concurrently with this Amendment No. 3 entering
into an amendment to the Amended and Restated Asset Purchase Agreement, dated as
of October 12, 2005, as amended November 30, 2005; and

 

WHEREAS, for purposes of this Amendment No. 3, capitalized terms not otherwise
defined herein shall have the respective meanings set forth in the Marketing
Representation Agreement;

 

NOW, THEREFORE, in consideration of the mutual promises contained herein, the
recitals set forth above, which are hereby incorporated by reference, and for
other good and valuable consideration, the receipt and sufficiency of which is
hereby acknowledged, the parties agree as follows:

 

1. Term. Section 7.1(c) shall be amended by deleting the date “February 15,
2006” and inserting in lieu thereof the date “March 31, 2006”.

 

2. Other Terms Unchanged. The Marketing Representation Agreement, as amended by
this Amendment No. 3, shall remain and continue in full

--------------------------------------------------------------------------------

force and effect, shall constitute a legal, valid and binding obligation of
Novoste, Representative and BMI and is in all respects agreed to, ratified and
confirmed hereby. Any reference to the Marketing Representation Agreement after
the date first set forth above shall be deemed to be a reference to the
Marketing Representation Agreement, as amended by this Amendment No. 3.

 

3. Governing Law. This Amendment No. 3 shall be governed by the substantive laws
of the State of Georgia, without regard to conflict-of-laws issues.

 

4. Counterparts. This Amendment No. 3 may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same document.

 

5. Titles and Captions. Section headings are used for convenience and shall not
affect the interpretation or construction of any provision of this Amendment
No. 3.

 

[Remainder of Page Intentionally Left Blank]

--------------------------------------------------------------------------------

Accepted and agreed to by the parties by their duly authorized representatives
as of the date first set forth above.

 

NOVOSTE CORPORATION   BEST VASCULAR, INC. By:  

/s/ Alfred J. Novak

--------------------------------------------------------------------------------

  By:  

/s/ Shawn R. Weingast

--------------------------------------------------------------------------------

Title:   President and Chief Executive Officer   Title:   General Counsel Date:
  January 27, 2006   Date:   January 27, 2006 BEST MEDICAL INTERNATIONAL, INC.  
      By:  

/s/ Alfred J. Novak

--------------------------------------------------------------------------------

        Title:   General Counsel         Date:   January 27, 2006